Riaan’s Therapeutic Odyssey – Chapter 5: The Family
Oct 1, 2026
In the final installment of this series, Riaan and his family face the unknown after five years of developing a genetic medicine for Cockayne syndrome.
Read More –Urine RNA Test Could Detect Bladder Cancer and Predict Treatment Response
Oct 2, 2026Plasma Epigenomic Profiling May Enable Noninvasive Subtyping of Small-Cell Lung Cancer
Oct 2, 2026Oncolytic Virus May Boost First-in-Line Chemotherapy for Metastatic PDAC
Sep 30, 2026Beyond Liquid Biopsy: Blood Reveals Cancer Targets—and the T Cells to Attack Them
Sep 30, 2026Exercise Improves Cognition and Biological Aging After Breast Cancer
Sep 30, 2026Rise in Infectious Disease-Caused Cancers Spurs Need for More Prevention
Sep 30, 2026CRISPR-Based Test Offers Fast Antimicrobial Resistance Detection in Low-Resource Settings
Oct 2, 2026
SARS-CoV-2 Immunity Broadly Applicable to Related Coronavirus Infections
Oct 1, 2026
Wearable Monitor Could Bring Real-Time Tracking to Stroke Rehabilitation
Sep 30, 2026
Hyperreactive Astrocytes Identified as Potential Driver of Tuberous Sclerosis Brain Lesions
Sep 30, 2026
Cutting Sugar When Taking Antibiotics Benefits Gut Microbiome
Sep 30, 2026
Radiation Omission Linked to Lower Long-Term Breast Cancer Endocrine Therapy Adherence
Sep 30, 2026
News & Features
Gene-Edited CAR T Expands Rare Disease Horizons
August 01, 2026Combining CAR T with CRISPR or TALEN is enabling more precise, scalable cell therapies for autoimmune, fibrotic, and genetic disorders.
From Mila to Many: Making Ultra-Rare Disease Therapies More Accessible
August 01, 2026Newer options like the therapies being developed by Forster and colleagues at Nerai Biosciences, alongside others like potentially curative gene therapies, are on the horizon…
Drug Repurposing’s Next Challenge: Turning Discoveries Into Treatments
August 01, 2026The U.S. Food and Drug Administration (FDA) is now actively involving patients, researchers, and clinicians in efforts to prioritize drug repurposing in areas where commercial…
Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows
In this IPM webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology.
Surbhi Jain, PhD, MBBS
Staff Scientist
Bio-Rad Laboratories
Prithwish Pal, PhD
Director, Global Product Marketing – Oncology
Bio-Rad Laboratories
AI Reads 3D Chromatin Images to Track Aging in Blood Stem Cells
Sep 28, 2026A deep learning model can distinguish young from aged blood stem cells by reading subtle changes in nuclear architecture, opening a potential route to image-based…
Proliferative Pause Reveals Window to Prevent Brain Metastasis
Sep 28, 2026Researchers identified a transient proliferative pause that makes early brain micrometastases vulnerable to treatment, potentially opening a path to prevent metastatic progression and postsurgical relapse.
Thermostable Formulation Could Free mRNA Vaccines from the Cold Chain
Sep 28, 2026MIT researchers used AI to develop thermostable mRNA vaccine formulations that retained bioactivity at high temperatures and could enable vaccine delivery through dissolvable microneedle patches.
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.
